Adaptive MicroRNA Delivery Systems for Specialized Environments

Publication ID: 24-11857633_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive MicroRNA Delivery Systems for Specialized Environments,” Published Technical Disclosure No. 24-11857633_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857633_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,633.

Summary of the Inventive Concept

This inventive concept adapts phosphorothioate-conjugated miRNAs for specialized environments, such as disaster relief, high-security needs, and extreme weather conditions, enabling targeted delivery and improved efficacy in niche applications.

Background and Problem Solved

The original patent disclosed phosphorothioate-conjugated miRNAs for treating multiple myeloma and inhibiting IL-6 signaling. However, these miRNAs may not be suitable for extreme environments or specialized applications. This inventive concept addresses the limitations of the original patent by developing adaptable miRNA delivery systems for specific, high-need markets.

Detailed Description of the Inventive Concept

The inventive concept comprises a microRNA delivery platform adapted for extreme weather conditions, high-security data storage using phosphorothioate-conjugated miRNAs, a portable miRNA delivery unit for emergency response, a microRNA-based detection system for biodefense, and environmental remediation using phosphorothioate-conjugated miRNAs. These systems and methods leverage the original patent's miRNA conjugates to target specific applications, ensuring improved efficacy and stability in challenging environments.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original patent's miRNA conjugates, including temperature and humidity resistance, secure encryption protocols, solar-powered portable units, and multi-pathogen detection capabilities. These specialized features and functionalities constitute the inventive step, distinguishing the new concept from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include miRNA delivery systems for space exploration, agricultural applications, or veterinary medicine. Variations could involve different types of miRNA conjugates, alternative encryption protocols, or modified detection systems.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including disaster relief, biodefense, environmental remediation, and high-security data storage. Target markets could include government agencies, emergency response organizations, and private companies operating in extreme environments.

CPC Classifications

SectionClassGroup
A A61 A61K47/549
A A61 A61K47/548
A A61 A61K48/00
C C12 C12N15/113
C C12 C12N2310/141
C C12 C12N2320/30

Original Patent Information

Patent NumberUS 11,857,633
TitlePhosphorothioate-conjugated miRNAs and methods of using the same
Assignee(s)City of Hope